Pharmaceutical companies are finding it a must to be sure of a compound’s value and increase product support before entering regulatory and reimbursement initiatives. Often, the patient perspective offers valuable insight to a product’s clinical impact and its commercial potential. Cutting Edge Information’s latest patient-reported outcomes (PRO) benchmarking report provides detailed metrics that showcase PRO team resources as well as PRO strategy, implementation and impact. Available for purchase here. (Source: Cutting Edge Information)
You are here: / / Looking To Improve Your Market Access Initiative?